ICU Medical, Inc. (NASDAQ:ICUI) Shares Bought by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. raised its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 66.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,000 shares of the medical instruments supplier's stock after acquiring an additional 8,400 shares during the period. Hussman Strategic Advisors Inc. owned approximately 0.09% of ICU Medical worth $2,916,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock worth $416,176,000 after purchasing an additional 17,805 shares during the period. JPMorgan Chase & Co. grew its stake in shares of ICU Medical by 7.4% during the 4th quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock worth $109,920,000 after purchasing an additional 49,108 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of ICU Medical by 18.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock worth $83,788,000 after purchasing an additional 82,982 shares during the period. Northern Trust Corp grew its stake in shares of ICU Medical by 11.1% during the 4th quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock worth $62,431,000 after purchasing an additional 40,187 shares during the period. Finally, Norges Bank acquired a new stake in shares of ICU Medical during the 4th quarter worth approximately $40,151,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Raymond James Financial dropped their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research note on Friday, May 9th. Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. KeyCorp reduced their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, ICU Medical presently has an average rating of "Buy" and a consensus target price of $192.67.

Insider Buying and Selling

In related news, COO Christian B. Voigtlander sold 4,985 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $128.50, for a total value of $640,572.50. Following the transaction, the chief operating officer directly owned 6,088 shares in the company, valued at approximately $782,308. This represents a 45.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director David C. Greenberg sold 1,942 shares of ICU Medical stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total transaction of $278,987.72. Following the completion of the sale, the director owned 6,760 shares of the company's stock, valued at $971,141.60. This trade represents a 22.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 36,097 shares of company stock worth $4,860,156 in the last three months. Company insiders own 1.50% of the company's stock.

ICU Medical Price Performance

Shares of NASDAQ:ICUI traded up $0.85 during trading on Monday, reaching $123.32. The stock had a trading volume of 15,023 shares, compared to its average volume of 255,036. ICU Medical, Inc. has a 1-year low of $117.92 and a 1-year high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.52 and a current ratio of 2.59. The stock has a market cap of $3.04 billion, a PE ratio of -32.13 and a beta of 0.87. The business has a fifty day moving average price of $132.57 and a 200-day moving average price of $143.80.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 EPS for the quarter, beating the consensus estimate of $1.23 by $0.49. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The firm had revenue of $599.49 million during the quarter, compared to analysts' expectations of $574.15 million. During the same quarter last year, the firm earned $0.96 earnings per share. The business's revenue for the quarter was up 6.7% on a year-over-year basis. On average, equities analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.